Tetramer/APC - HLA-A*02:01 Tyrosinase (YMDGTMSQV)

Catalog No:
MBL-TS-0019-2

Availability: 12PM PT on Dec. 3, 2024

Formerly Catalog No.: TB-0019-2

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application FC
Reactivity Human
Conjugation APC
Peptide Sequence YMDGTMSQV

Citations for Tetramer/APC - HLA-A*02:01 Tyrosinase (YMDGTMSQV) – 1 Found
Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4.  PubMed